Drug Safety

At OBS Pharma, “Patient Safety First” is our highest priority. We strictly adhere to Good Pharmacovigilance Practices (GVP) in compliance with applicable local and global regulatory requirements. Our robust reporting, monitoring, and tracking systems ensure the continuous evaluation of product safety throughout the product lifecycle.

If you experience or become aware of any Suspected Adverse Drug Reaction (ADR), Adverse Event or Product Complaint related to our marketed brands, we encourage you to report it using the form available at the links below.

Your timely reporting helps us maintain the highest standards of safety and care for patients worldwide.

• Adverse Event Reporting (in Accordance with ICH E2C(R2) Guidelines)
• Product Quality Complaint Form